Senzar Asset Management as of Sept. 30, 2014
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 29 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mylan | 9.4 | $32M | 706k | 45.50 | |
| GlaxoSmithKline | 9.0 | $31M | 668k | 45.97 | |
| Teva Pharmaceutical Industries (TEVA) | 9.0 | $31M | 568k | 53.75 | |
| Sanofi-Aventis SA (SNY) | 8.1 | $28M | 488k | 56.41 | |
| Covidien | 7.4 | $25M | 292k | 86.56 | |
| Abbvie (ABBV) | 7.3 | $25M | 431k | 57.80 | |
| Enanta Pharmaceuticals (ENTA) | 6.6 | $22M | 567k | 39.55 | |
| Community Health Systems (CYH) | 5.1 | $17M | 315k | 54.79 | |
| Medtronic | 4.3 | $15M | 238k | 61.95 | |
| Magellan Health Services | 3.4 | $11M | 208k | 54.77 | |
| Allergan | 3.0 | $10M | 57k | 178.18 | |
| CONMED Corporation (CNMD) | 2.8 | $9.6M | 260k | 36.91 | |
| Orthofix International Nv Com Stk | 2.7 | $9.3M | 302k | 30.96 | |
| Biogen Idec (BIIB) | 2.6 | $8.8M | 27k | 330.00 | |
| Insmed (INSM) | 2.5 | $8.7M | 663k | 13.05 | |
| Repros Therapeutics | 2.2 | $7.5M | 754k | 9.90 | |
| XenoPort | 2.1 | $7.2M | 1.3M | 5.38 | |
| Rite Aid Corporation | 1.8 | $6.0M | 1.2M | 4.84 | |
| Momenta Pharmaceuticals | 1.5 | $5.2M | 455k | 11.34 | |
| Sagent Pharmaceuticals | 1.4 | $4.8M | 155k | 31.10 | |
| WellCare Health Plans | 1.3 | $4.6M | 76k | 60.34 | |
| Rigel Pharmaceuticals | 1.2 | $4.0M | 2.1M | 1.94 | |
| Five Prime Therapeutics | 1.0 | $3.5M | 298k | 11.73 | |
| Corium Intl | 1.0 | $3.4M | 559k | 6.14 | |
| Concert Pharmaceuticals I equity | 1.0 | $3.3M | 261k | 12.61 | |
| Acelrx Pharmaceuticals | 0.9 | $3.0M | 554k | 5.49 | |
| Retrophin | 0.8 | $2.6M | 292k | 9.02 | |
| Kythera Biopharmaceuticals I | 0.6 | $2.2M | 66k | 32.86 | |
| Biota Pharmaceuticals | 0.1 | $244k | 99k | 2.47 |
